التفاصيل البيبلوغرافية
| العنوان: |
Use of ciclesonide for the treatment of inflammatory bowel diseases |
| Document Number: |
20060211668 |
| تاريخ النشر: |
September 21, 2006 |
| Appl. No: |
10/570986 |
| Application Filed: |
September 15, 2004 |
| مستخلص: |
The invention relates to the novel use of ciclesonide in the treatment of inflammatory bowel disease. |
| Inventors: |
Abel, Florian (Bondmann-Ludwigshafen, DE); Brueck, Antje (Konstanz, DE); Dietzel, Klaus (Konstanz, DE); Eistetter, Klaus (Konstanz, DE); Nave, Ruediger (Konstanz, DE); Postius, Stefan (Konstanz, DE); Von Richter, Oliver (Kontanz, DE) |
| Assignees: |
ALTANA PHARMA AG (Konstanz, DE) |
| Claim: |
1.-6. (canceled) |
| Claim: |
7. A pharmaceutical composition comprising a therapeutically effective amount of ciclesonide and a pharmaceutically acceptable carrier and/or excipient suitable for oral administration allowing targeted release of ciclesonide in the small intestine and/or colon. |
| Claim: |
8. The pharmaceutical composition according to claim 7, comprising a core formulation containing ciclesonide and a coating providing a release profile allowing targeted release of ciclesonide in the small intestine and/or colon. |
| Claim: |
9. The pharmaceutical composition according to claim 8, wherein the core formulation is a granulate, a pellet or a tablet. |
| Claim: |
10. The pharmaceutical composition according to claim 9, wherein the core formulation is an immediate release formulation. |
| Claim: |
11. The pharmaceutical composition according to claim 8, comprising at least one enteric coating and/or at least one slow release coating. |
| Claim: |
12. The pharmaceutical composition according to claim 11, comprising a combination of one enteric coating and one slow release coating. |
| Claim: |
13. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof. |
| Claim: |
14. The method according to claim 13, wherein the inflammatory bowel disease is selected from the group consisting of Crohn's disease and ulcerative colitis. |
| Claim: |
15. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof, wherein the ciclesonide is administered in a pharmaceutical composition according to claim 7. |
| Claim: |
16. The method according to claim 13, wherein ciclesonide is administered rectally. |
| Claim: |
17. The pharmaceutical composition according to claim 7, wherein more than 95% of the ciclesonide present is in the form of its R epimer. |
| Claim: |
18. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof, wherein the ciclesonide is administered in a pharmaceutical composition according to claim 8. |
| Claim: |
19. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof, wherein the ciclesonide is administered in a pharmaceutical composition according to claim 9. |
| Claim: |
20. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof, wherein the ciclesonide is administered in a pharmaceutical composition according to claim 10. |
| Claim: |
21. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof, wherein the ciclesonide is administered in a pharmaceutical composition according to claim 11. |
| Claim: |
22. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof, wherein the ciclesonide is administered in a pharmaceutical composition according to claim 12. |
| Claim: |
23. A method of treatment of inflammatory bowel disease in a patient comprising administering a therapeutically effective amount of ciclesonide to the patient in need thereof, wherein the ciclesonide is administered in a pharmaceutical composition according to claim 17. |
| Current U.S. Class: |
514179/000 |
| Current International Class: |
61 |
| رقم الانضمام: |
edspap.20060211668 |
| قاعدة البيانات: |
USPTO Patent Applications |
